GNAT toxins evolve toward narrow tRNA target specificities

Dmitry Bikmetov(Kurchatov Institute), Alexander M. J. Hall(Harvard University), Alexei Livenskyi(Lomonosov Moscow State University), Bridget Gollan(Harvard University), Stepan V Ovchinnikov(Skolkovo Institute of Science and Technology), Konstantin Gilep(Institute of Gene Biology), J. Kim(Harvard University), Gerald Larrouy‐Maumus(Imperial College London), В. Г. Згода(Institute of Biomedical Chemistry), Sergei Borukhov(Rowan University), Konstantin Severinov(Skolkovo Institute of Science and Technology), Sophie Hélaine(Harvard University), Svetlana Dubiley(Skolkovo Institute of Science and Technology)
Nucleic Acids Research
May 5, 2022
Cited by 13Open Access
Full Text

Abstract

Type II toxin-antitoxin (TA) systems are two-gene modules widely distributed among prokaryotes. GNAT toxins associated with the DUF1778 antitoxins represent a large family of type II TAs. GNAT toxins inhibit cell growth by disrupting translation via acetylation of aminoacyl-tRNAs. In this work, we explored the evolutionary trajectory of GNAT toxins. Using LC/MS detection of acetylated aminoacyl-tRNAs combined with ribosome profiling, we systematically investigated the in vivo substrate specificity of an array of diverse GNAT toxins. Our functional data show that the majority of GNAT toxins are specific to Gly-tRNA isoacceptors. However, the phylogenetic analysis shows that the ancestor of GNAT toxins was likely a relaxed specificity enzyme capable of acetylating multiple elongator tRNAs. Together, our data provide a remarkable snapshot of the evolution of substrate specificity.


Related Papers

No related papers found

Powered by citation graph analysis